Compare Humana Inc (HUM) vs Liberty Global Ltd Class C (LBTYK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs Liberty Global Ltd Class C — how do they compare? Humana Inc trades at $444.74 (market cap $46.49B), while Liberty Global Ltd Class C trades at $8.79 (market cap $3.06B). The key difference: Humana Inc is far larger — about 15.2× Liberty Global Ltd Class C's market cap, and Humana Inc pays a 0.91% dividend while Liberty Global Ltd Class C pays none. Which is the better fit depends on your goals — on Pluang, investors hold Humana Inc for 53 Days and Liberty Global Ltd Class C for 21 Days on average.
| HUM | LBTYK | |
|---|---|---|
Market Cap | $46.49B | $3.06B |
Volume | 2,567,704 | 2,508,956 |
Sector | Health | Media |
52-Week High | $409.85 | $12.67 |
52-Week Low | $163.67 | $8.75 |
Typical Hold Time | 53 Days | 21 Days |
Enterprise Value | $53.84B | $9.72B |
Dividend Yield | 0.91% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $396.51, down 1.92% on the day, with strong technical momentum showing bullish moving averages and key support at $391. The company demonstrates consistent revenue growth reaching $129.7B in 2025, though net margins have compressed to 0.88%. Recent quarterly earnings have exceeded expectations, with Q2 2026 EPS of $7.61 beating estimates of $7.27. Analyst sentiment remains positive with a $432.63 consensus price target representing 9% upside potential from current levels.
The investment case centers on Humana's dominant Medicare Advantage position and consistent revenue growth, though margin pressure and regulatory scrutiny present headwinds. With 43% of analysts maintaining buy ratings and institutional accumulation continuing, the stock offers exposure to healthcare demographics but requires monitoring of enrollment trends and cost management execution.
LBTYK is trading at $8.92, down 0.28% on the day, and is near its 52-week low. The stock shows a bearish technical trend with mixed earnings, including a recent Q1 2026 beat but a Q2 2026 miss. Financially, it has a negative net income margin of -62.14% for 2026, though revenue remains stable at $4.9B. Recent news highlights strategic moves like the Ziggo Group spin-off planned for 2027 and an AI partnership to enhance customer experiences.
The outlook is cautious; while analyst consensus is bullish with a $12.67 price target, high losses and bearish technicals pose risks. Upside potential hinges on successful asset monetization and the Ziggo listing, but investors face volatility from ongoing profitability challenges and market sentiment shifts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About Liberty Global Ltd Class C
Liberty Global is a world leader in converged broadband, video, and mobile communications. It operates large-scale fiber and 5G networks across Europe, providing essential digital services to millions of customers.
Read more on LBTYK →
